Disclosures for "Missed or Delayed Infusions as Probable Culprits for Relapses in NMOSD Patients on Inebilizumab: A Real-world Study in a Predominantly Hispanic Cohort"
-
Ms. Salinas Leal has nothing to disclose.
-
The institution of Dr. Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. The institution of Dr. Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. The institution of Dr. Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AMGEN. The institution of Dr. Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion.
-
Mrs. Rodriguez has nothing to disclose.